CClinicalTrials.gg
Status unknownNCT05599594Updated Oct 26, 2023

Premenstrual Symptoms and Aromatherapy

An interventional study of Aromatherapy in Premenstrual Syndrome and Aromatherapy, sponsored by KTO Karatay University. Status unknown at 1 site in Turkey. Open to female participants aged 18 Years to 30 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-10-26.

Sponsored by KTO Karatay University · Not applicable, Interventional, and Supportive care

The sponsor has not verified this record recently (last verified Dec 2022), so the status shown — last known as Not yet recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
120
Allocation
Randomized
Ages
18 Years to 30 Years
Sex
Female
01

Study summary

Aromatherapy is the science of using high concentrated essential oils or essences with distilled high concentration of plants to take advantage of therapeutic properties '' . Essential oils or essences are obtained from various parts of plants (root, leaf, flower, shell, fruit) and therapeutically used for physical and psychological favors. The aromatherapine is a noninvasive process and the convenience of use allows the widespread use of aromatherapy. Aromatic oils can be applied in four basic ways. These are topical (tap, compressed or bath), internal (mouthwash, vaginal or anal wick), mouth (with capsules or honey, alcohol or diluent) and inhalation (inhalation directly or indirectly, steam or vapor ) is the way . Volatile oils that can be applied in various means can reach the neocortex part of the brain directly with the links to the hypothalamus from the limbic system. As a result of the impact of aromatic oils on the central nervous system, relief, sedation or stimulating effects are formed and the energy blockage in the body is broken, due to the information stream reaching the brain with the warning of the central nervous system and the resulting energy is exposed. The improvement process is supported by its exposed energy stream in a balanced way of the relevant organs, and the state of physical and spiritual goodness is emerged. Aromatherapy is also used in the field of women's health as well as many health areas.

Read the detailed description

Premenstrual syndrome is a health problem characterized by mitigation of symptoms in several days after the beginning of menstruals, or after the beginning of menstruals, which occurs in the Luteal phase of menstrual cycle in the luteal phase . About 80-95% of women complained of premenstrual syndrome complaints. This ratio is affected by physical, cognitive, emotional and behavioral symptoms in different occupational groups in serious dimension, it can negatively affect life from business life to family life, and when it is considered to be repeated each month, the quality of life is negatively affected. In this reason the premenstrual symptoms The minimization of complaints and minimizing complaints constitutes a state of need.

In the studies involved in the literature, women complaining about Premenstrual Syndrome complaints were applied to various essential oils (Rose, Sardinia, Sage, Lavender) aromatherapy and stated that depression, anxiety, anxiety, irritability pain perception decreased by both psychological and physical positive effects.

In Turkey, the trend of traditional and complementary medicine is increasing day by day. However, aromatherapy practices are common in Turkey as well as aromatherapy practices in the world. The aromatic oils are diluted and ready to use are a method in pharmacies, as well as in pharmacies, as well as people want to use and use. The cost of ready-to-use aromatic oils will provide the treatment option to women in the light of new evidence in line with the fact that it is cheap and easily accessible to the study .

02

Conditions studied

  • Premenstrual Syndrome
  • Aromatherapy

Browse trials for

Keywords

  • Aromatherapy
  • Premenstrual symptom
  • Quality of life
03

In context

Premenstrual Syndrome

177 studies on the registry are indexed under Premenstrual Syndrome; 30 are open to participants now.

This study's planned enrollment of 120 is above the median of 70 across 153 interventional studies indexed under Premenstrual Syndrome.

Browse Premenstrual Syndrome studies →

Lead sponsor

KTO Karatay University is the lead sponsor of 126 studies on the registry; 16 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 30 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes

Inclusion criteria

  • Premenstrual is at least 5 of the complaints living (self-notice),
  • Non-respiratory disease such as asthma, bronchitis (self-notice),
  • Not allergic to fat to be used (self-notice),
  • Pregnancy or pregnancy doubt (self-notice),
  • Diabetes, hypertension without a systemic discomfort (self-notice)

Exclusion criteria

Exclusion Criteria:

  • Premenstrual has not experienced complaints,
  • Using cigarettes or alcohol,
  • With chronic discomfort (respiratory diseases),
  • Pregnancy suspected or conceived,
  • With a systemic discomfort such as diabetes, hypertension,
  • Individuals who do not want to participate in the study
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
120 participants (estimated)

Study arms

  • Experimental
    Neroli oil

    Neroli oil improves the quality of life by reducing premenstrual symptoms with relaxing and calming effect.

    Other: Aromatherapy

  • Experimental
    Lemongrass oil

    Lemongrass oil improves the quality of life by reducing premenstrual symptoms with relaxing and calming effect.

    Other: Aromatherapy

Interventions

  • OtherAromatherapy

    6 drops of aromatic oils used by the researcher will be dripped by the aromatic oils to take the fragrance by inhalation for 30 minutes.

06

What researchers measure

Primary outcomes

  1. Personal Information Form

    A questionnaire with 12 questions was created by the researchers. The filling time of the participants is 5-6 minutes.

    Time frame: 1 year

  2. Premenstrual Syndrome Scale

    Participants in the study will be asked to fill in this scale in the pre-test. Women with premenstrual syndrome will be included in the study.The application of the premenstrual syndrome scale is made by evaluating the person retrospectively, taking into account the "being in the period one week before the period". The total score is obtained from the sum of the scores from all sub-dimensions. A minimum of 44 and a maximum of 220 points can be obtained from the scale. An increase in the score obtained from the scale indicates an increase in the intensity of the symptoms. If the total scale score (220) exceeds 50% (110) in the PMS scale, PMS is considered as "present".

    Time frame: 1 year

Secondary outcomes

  1. Scale for Coping With Premenstrual Symptoms

    Participants will be asked to fill in this scale both in the pretest and the posttest.No evaluation is made on the total score of the Scale for Coping with Premenstrual Symptoms. As the score obtained from the sub-dimensions of the scale increases, coping with premenstrual symptoms increases. The scale structure consisting of thirty-two items explains 38.9% of the variance. In addition, the sub-dimensions of the scale are in a significant relationship with each other, and the correlation coefficients range from 0.188 to 0.518. Cronbach's alpha safety coefficients of the sub-dimensions of the Turkish version of PSSS were ''harm avoidance-0.88'', ''awareness and acceptance of premenstrual changes -0.89'', ''adapting energy -0.75'', ''self-care-0.83''. ' is 'communication-0.86''.

    Time frame: 1 year

  2. SF-36 Quality of Life Scale

    Participants will be asked to fill in this scale both in the pretest and the posttest.The scale consists of eight sub-dimensions for physical function, physical role limitations, emotional role limitations, vitality (life energy), social function, pain, mental health and general perception of health. A separate score is obtained for each subscale. SF-36 evaluates the positive as well as the negative aspects of the health condition. Sub-dimension scores range from 0 to 100. Scores are positively oriented. Increasing score indicates better quality of life.

    Time frame: 1 year

07

Study locations

1 site
  • KTO Karatay University
    Konya, 42000, Turkey
    • Şerife İrem DÖNER · Principal investigator
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Oct 26, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05599594
Lead sponsor
KTO Karatay University
Responsible party
Sponsor
First posted
Oct 31, 2022
Start date
Dec 15, 2023 (estimated)
Primary completion
Jan 30, 2024 (estimated)
Completion
Jul 30, 2024 (estimated)
Last update
Oct 26, 2023

Study contacts

Hafize DAĞ TÜZMEN, Phd, Student Nursing
Contact
hafize.dag.tuzmen@karatay.edu.tr
05357446142
Füsun SUNAR, Associate Professor
principal investigator · Kto Karatay Üniversitesi

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Dec 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion